Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Merck’s cholesterol drug clears main goal in late-stage study

Merck & Co. Inc. said its experimental cholesterol drug met the main goal of reducing coronary heart diseases in a late-stage study, sending the company’s shares up 2.4 percent in premarket trading.

Read More »

Dimension Therapeutics Pink Slips 25 Percent of Workforce

As part of a strategic review, Cambridge, Mass.-based Dimension Therapeutics plans to cut 25 percent of its staff by the end of 2017.

Read More »

New form of Roche’s Esbriet approved in Europe for lung disorder

Roche said a new Esbriet tablet formulation was approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF), a fatal condition that causes irreversible, progressive scarring of the lungs.

Read More »

Novartis gets European OK for biosimilar of Amgen’s Enbrel

Novartis’ generics unit Sandoz said the European Commission approved Erelzi – the company’s biosimilar to Amgen’s Enbrel – to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis.

Read More »

Mobile Technology in Heart Failure Clinical Trials: Connecting with Patients Where They Live and Work

Management of heart failure can be overwhelming for patients and their caregivers. To help address this, a new study has been launched assessing patient-facing mobile health technologies to improve adherence to medication and to self-care routines such as physical activity and following fluid and sodium restrictions. Known as the Care Optimization through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT HF), this quality improvement study is enrolling high-risk, hospitalized patients with acute heart failure and reduced ejection fraction.

Read More »

U.S. Senate Republicans to issue revised healthcare bill: Senate aide

U.S. Senate Republicans are expected to issue a revised version of their healthcare bill, according to a Republican Senate aide, as the chamber’s leaders scurried to win support and get the bill passed by a July 4 holiday recess.

Read More »

EU tests limits of drug pricing freedom in landmark probe

The first ever EU antitrust probe into excessive drug pricing is taking the European pharmaceuticals industry into uncharted territory, unnerving some companies and lawyers worried about the reach of market intervention.

Read More »

Medtronic deal with Aetna ties insulin pump payment to patient results

Medtronic Plc said it signed an agreement with health insurer Aetna Inc. under which payment for its insulin pump systems will be tied to how well diabetes patients fare after switching from multiple daily insulin injections.

Read More »

Just how to Appear Stylish over a Budget

The author should to have a great article writing skills and potentials. That’s because they’re still not certain the way to approach essay writing. As this article is merely about how to begin writing good Language arrangements, let’s now dive right in to that. Composing an autobiography is an extremely big task. As an example […]

Read More »

FDA Approves First Anticoagulant for Hospitals

Portola Pharmaceuticals announced that the U.S. Food and Drug Administration approved the potential blockbuster drug Bevyxxa (betrixaban).

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom